Financial Gravity Companies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Financial Gravity Companies's VRTX Position: Q4 2018 in Review
Financial Gravity Companies opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2018: 1,075 shares worth $206K. The stake represents 0.19% of the portfolio and ranks #124 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in VRTX as recently as Q1 2018.
Financial Gravity Companies first reported a position in VRTX in Q4 2017 and has held it in 3 quarters since. 705 funds tracked by Wall St. Rank hold VRTX as of Q4 2018.
- Financial Gravity Companies held 1,075 shares of Vertex Pharmaceuticals worth $206K as of Q4 2018.
- Vertex Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
- Vertex Pharmaceuticals made up 0.19% of Financial Gravity Companies's portfolio in Q4 2018, its #124 holding.
- Financial Gravity Companies first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
- 705 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2018.
Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.